Hyperbaric oxygen therapy can be recommended for stage I and II osteoradionecrosis. - GreenMedInfo Summary
The efficacy of hyperbaric oxygen therapy related to the clinical stage of osteoradionecrosis of the mandible.
Int J Oral Maxillofac Surg. 2016 Dec 30. Epub 2016 Dec 30. PMID: 28043745
F J Dieleman
This study aimed to evaluate the success of hyperbaric oxygen therapy (HBOT) and surgery in the treatment of mandibular osteoradionecrosis (ORN) in relation to the extent of the ORN. Twenty-seven patients with ORN were identified from a total of 509 patients with a history of primary oral or base of the tongue cancer; these patients had been treated with radiation therapy with curative intent between 1992 and 2006, with a radiation dose to the mandible of≥50Gy. The ORN was staged according to the classification of Notani et al. The time from completion of radiation therapy to the development of ORN varied (median 3 years). Forty HBOT sessions were offered. After HBOT alone, 3 of 11 stage I lesions, 0 of 8 stage II lesions, and 0 of 8 stage III lesions had healed (P=0.0018). An absolute incidence of 5.3% ORN was found in this population. Of all sites irradiated in this study, the floor of the mouth was most associated with ORN (8.6%), whereas the cheek was least associated (0%). Based on the results of this study, HBOT can be recommended forstage I and II ORN and for selected cases of stage III ORN.